Home › Bids
› Innovative Screening Approaches and Therapies for Screenable
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Open580 days leftHealthcaregrant
Dec 2, 2024
Nov 16, 2027 12:00 AM
Healthcare
grant
...
AI Summary
This is a funding opportunity (grant) for innovative screening approaches and therapies for screenable disorders in newborns. The grant is an R21 Clinical Trial Optional grant, and the CFDA number is 93.865.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.